BioCentury
ARTICLE | Company News

Alexza, Ferrer deal

November 17, 2014 8:00 AM UTC

The companies eliminated undisclosed milestone payments under a 2011 deal granting Grupo Ferrer exclusive rights to commercialize bipolar disorder and schizophrenia product Adasuve loxapine in Europe...